1. Home
  2. A vs GEHC Comparison

A vs GEHC Comparison

Compare A & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • A
  • GEHC
  • Stock Information
  • Founded
  • A 1999
  • GEHC 1892
  • Country
  • A United States
  • GEHC United States
  • Employees
  • A N/A
  • GEHC N/A
  • Industry
  • A Biotechnology: Laboratory Analytical Instruments
  • GEHC Computer Software: Prepackaged Software
  • Sector
  • A Industrials
  • GEHC Technology
  • Exchange
  • A Nasdaq
  • GEHC Nasdaq
  • Market Cap
  • A 29.3B
  • GEHC 32.5B
  • IPO Year
  • A 1999
  • GEHC N/A
  • Fundamental
  • Price
  • A $121.38
  • GEHC $75.96
  • Analyst Decision
  • A Buy
  • GEHC Strong Buy
  • Analyst Count
  • A 13
  • GEHC 10
  • Target Price
  • A $139.67
  • GEHC $88.80
  • AVG Volume (30 Days)
  • A 1.8M
  • GEHC 3.8M
  • Earning Date
  • A 08-20-2025
  • GEHC 07-30-2025
  • Dividend Yield
  • A 0.82%
  • GEHC 0.18%
  • EPS Growth
  • A N/A
  • GEHC 38.77
  • EPS
  • A 4.06
  • GEHC 4.76
  • Revenue
  • A $6,628,000,000.00
  • GEHC $19,799,000,000.00
  • Revenue This Year
  • A $6.13
  • GEHC $5.19
  • Revenue Next Year
  • A $5.64
  • GEHC $4.71
  • P/E Ratio
  • A $29.89
  • GEHC $15.98
  • Revenue Growth
  • A 0.56
  • GEHC 1.56
  • 52 Week Low
  • A $96.43
  • GEHC $57.65
  • 52 Week High
  • A $153.84
  • GEHC $94.80
  • Technical
  • Relative Strength Index (RSI)
  • A 63.54
  • GEHC 64.77
  • Support Level
  • A $116.84
  • GEHC $73.57
  • Resistance Level
  • A $123.16
  • GEHC $76.83
  • Average True Range (ATR)
  • A 2.56
  • GEHC 1.50
  • MACD
  • A 0.18
  • GEHC 0.38
  • Stochastic Oscillator
  • A 81.18
  • GEHC 89.71

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Share on Social Networks: